149 related articles for article (PubMed ID: 38679449)
1. An Inevitable Challenge in Primary Prevention of Upper Gastrointestinal Bleeding Among Aspirin Users: Appropriate Use of Proton Pump Inhibitors.
Ito H
Am J Med; 2024 May; 137(5):e98. PubMed ID: 38679449
[No Abstract] [Full Text] [Related]
2. [Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
Bretagne JF
Presse Med; 2009 Dec; 38(12):1722-6. PubMed ID: 19914029
[No Abstract] [Full Text] [Related]
3. Cost-utility of aspirin and proton pump inhibitors for primary prevention.
Earnshaw SR; Scheiman J; Fendrick AM; McDade C; Pignone M
Arch Intern Med; 2011 Feb; 171(3):218-25. PubMed ID: 21325111
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
5. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Aspirin Prescribing and Gastrointestinal Bleeding in Adults 60 Years of Age and Older in a Large, Academic Health System.
Potthast KL; Billups SJ; Fixen DR; Titus O; Saseen JJ; Linnebur SA
Sr Care Pharm; 2024 Jun; 39(6):218-227. PubMed ID: 38803024
[No Abstract] [Full Text] [Related]
8. Should patients stop taking aspirin for primary prevention?
Depta JP; Bhatt DL
Cleve Clin J Med; 2015 Feb; 82(2):91-6. PubMed ID: 25897597
[No Abstract] [Full Text] [Related]
9. Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding.
Yang SC; Wu CK; Tai WC; Liang CM; Yao CC; Wu KL; Hsu CN; Chuah SK
J Gastroenterol Hepatol; 2021 Jul; 36(7):1828-1835. PubMed ID: 33247982
[TBL] [Abstract][Full Text] [Related]
10. Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding.
Tan HJ; Mahadeva S; Menon J; Ng WK; Zainal Abidin I; Chan FK; Goh KL; ;
J Dig Dis; 2013 Jan; 14(1):1-10. PubMed ID: 23134105
[TBL] [Abstract][Full Text] [Related]
11. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
Morini S; Zullo A
G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
[No Abstract] [Full Text] [Related]
12. Hospitalisation and associated costs of gastrointestinal bleeding from primary prevention aspirin use in South Australia: a retrospective case series analysis.
Roberts G; Baker M; Leiblich H; Paulose M; Pegoli M; Panagopoulos L; Schiller C; Suppiah V
Intern Med J; 2022 Feb; 52(2):318-321. PubMed ID: 35187830
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and clopidogrel.
Gaglia MA; Waksman R
Cardiovasc Ther; 2010 Jun; 28(3):169-76. PubMed ID: 20345494
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?
Moayyedi P; Sadowski DC
Can J Gastroenterol; 2009 Apr; 23(4):251-2. PubMed ID: 19373416
[No Abstract] [Full Text] [Related]
15. Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding.
Struijk M; Postma DF; van Tuyl SA; van de Ree MA
Eur J Intern Med; 2012 Apr; 23(3):227-30. PubMed ID: 22385878
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and gastrointestinal toxicity.
Törüner M
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy and proton pump inhibition: cause for concern?
Depta JP; Bhatt DL
Curr Opin Cardiol; 2012 Nov; 27(6):642-50. PubMed ID: 23075823
[TBL] [Abstract][Full Text] [Related]
18. [Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].
Casado-Arroyo R; Muñoz-Villalenguas M; Lanas Arbeloa A
Gastroenterol Hepatol; 2011; 34(7):478-91. PubMed ID: 21684042
[TBL] [Abstract][Full Text] [Related]
19. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
20. Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.
Morneau KM; Reaves AB; Martin JB; Oliphant CS
J Manag Care Pharm; 2014 Feb; 20(2):187-93. PubMed ID: 24456320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
